AIM
MRNA icon

Acropolis Investment Management’s Moderna MRNA Stock Holding History

Acropolis Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,060
Closed -$429K – 215
2020
Q3 		$429K Hold
6,060
– – 0.05% 113
2020
Q2 		$389K Hold
6,060
– – 0.05% 113
2020
Q1 		$181K Hold
6,060
– – 0.03% 145
2019
Q4 		$119K Buy
+6,060
New +$108K 0.02% 157
2019
Q2 		– Sell
-6,060
Closed -$123K – 146
2019
Q1 		$123K Buy
+6,060
New +$112K 0.02% 134

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acropolis Investment Management's MRNA Position: Q4 2020 in Review

Acropolis Investment Management sold out of Moderna (MRNA) in Q4 2020, closing a stake of 6,060 shares — an estimated $429K sold.

Acropolis Investment Management first reported a position in MRNA in Q1 2019 and held it in 5 quarters. The position peaked at $429K in Q3 2020. 717 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • Acropolis Investment Management reported no remaining Moderna position as of Q4 2020 after selling out during the quarter.
  • Acropolis Investment Management sold 6,060 Moderna shares in Q4 2020, an estimated $429K.
  • Acropolis Investment Management first reported a position in Moderna in Q1 2019 and held it in 5 quarters.
  • Acropolis Investment Management's Moderna position peaked at $429K in Q3 2020.
  • 717 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on Acropolis Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.